Back to results

CompletedPhase 2

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)

NCT02689362

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centro de Estudos em Diabetes e Hipertensão

Fortaleza, Ceará, Brazil

+9 additional locations

View on ClinicalTrials.gov

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) — TrialFind